San Carlos, Calif.-based Natus Medical (NSDQ:BABY) lost a few more points after releasing its official Q2 earnings release, which was pretty much in line with the company’s preliminary report.
Q2
Endologix shares gain 5 points in days following Q2 report
Special charges devour Merit Medical’s bottom line in Q2
Merit Medical Systems (NSDQ:MMSI) saw its bottom line drop dramatically during its 2nd quarter, thanks in part to some high-value temporary expenses, but the device maker’s otherwise promising financials got some attention from Wall Street last week.
Cynosure falls back to earth after reporting Q2 results
ResMed settles down after earnings release high
Sales are flat, profits plunge in the 2nd quarter for Symmetry Medical
Symmetry Medical (NYSE:SMA) saw its 2nd-quarter profits plunge more than 28% on flat sales and lowered its outlook for the balance of the year.
Dentsply’s Q2 earnings rise despite flat sales
Dentsply International (NSDQ:XRAY) managed to boost its 2nd-quarter profits despite flat sales, saying headwinds in Europe will push down its earnings for the rest of the year.
Legal loss pushes Globus Medical’s Q2 earnings down
Globus Medical (NYSE:GMED) shares rose more than 2% last week despite a 61% 2nd-quarter profit slide after the medical device company reported earnings above Wall Street’s forecast and confirmed its outlook for the rest of the year.
Sirona Dental slides despite Street-beating Q3
Dental devices maker Sirona Dental Systems (NSDQ:SIRO) posted a strong quarter, but the boost in sales and widening profits didn’t stir much enthusiasm from Wall Street.